Cytometry Part B-Clinical Cytometry

Papers
(The TQCC of Cytometry Part B-Clinical Cytometry is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue highlights—January 202535
32
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring31
An uncommon case of acute megakaryoblastic leukemia with DDX3X::MLLT10 fusion gene29
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells24
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease20
Issue highlights—September 202319
18
Issue Information15
15
Issue Information15
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients14
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel14
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma13
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa13
Standardization of flow cytometric detection of antigen expression12
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis12
A 20‐color 21‐antigen flow cytometric assay for disease monitoring of T‐cell lymphoblastic leukemia12
Frequency and stability of populations of CD4+ and CD4+CD25+Foxp3+CD127lo Treg in healthy adults defi11
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia11
Issue Information11
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia11
Issue Information11
Issue Information10
ROR1 expression in mature B lymphoid neoplasms by flow cytometry10
Issue Highlights—January 202210
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric9
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow 9
Issue Information9
CD133 in T‐lymphoblastic leukemia is preferentially expressed in early T‐phenotype (ETP) and near ETP subtypes9
9
SingletSeeker: an unsupervised clustering approach for automated singlet discrimination in cytometry8
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR8
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry8
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT8
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia7
Imaging flow cytometry reveals a subset of TdT negative T‐ALL blasts with very low forward scatter on conventional flow cytometry7
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays7
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International 7
6
6
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry6
Quick identification of target antigens by tissue flow cytometry for CAR‐T therapy in B‐cell malignancies6
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis6
Issue Information6
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds5
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience5
Editorial on IVD cellular assay validation5
Possible alternative strategies to implement basophil activation testing in multicentric studies5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring5
5
Remembering Dr. Bruce H. Davis: A passionate leader in clinical flow cytometry5
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening5
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care4
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia4
Issue Highlights—November 20214
Intraoperative flow cytometry in detecting free carcinoma cells in peritoneal lavage fluid of gastric carcinoma cases4
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation4
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma4
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis4
Issue Highlights—July 20224
Patients without cutaneous T‐cell lymphoma frequently harbor CD4 T‐lymphocytes that lack CD26 and/or CD74
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome4
Issue Information4
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup4
0.065215110778809